Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.1703
H.R.1703: Medical Product Communications Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced March 23, 2017
- Latest Major Action March 24, 2017
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - March 23, 2017
Bill Summary
Medical Product Communications Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to state that the intended use of a drug, biological product, or device shall be determined by the objective intent of the manufacturer and sponsor of such drug, biological product, or device, as demonstrated by statements contained in labeling, advertising, or analogous oral statements. The intended use of these medical products shall not be...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
March 24, 2017 |
Referred to the Subcommittee on Health.
|
March 23, 2017 |
Referred to the House Committee on Energy and Commerce.
|
March 23, 2017 |
Introduced in the House by Morgan Griffith (R-Va.) |